[HTML][HTML] Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review
JV Selby, CCHM Maas, BH Fireman, DM Kent - medRxiv, 2024 - ncbi.nlm.nih.gov
Background: The Predictive Approaches to Treatment Effect Heterogeneity (PATH)
Statement provides guidance for using predictive modeling to identify differences (ie …
Statement provides guidance for using predictive modeling to identify differences (ie …
A moderately higher time-in-range threshold improves the prognosis of type 2 diabetes patients complicated with COVID-19
R Cong, J Zhang, L Xu, Y Zhang, H Wang… - Frontiers in …, 2024 - frontiersin.org
Objective After fully lifting coronavirus disease 2019 (COVID-19) pandemic control
measures in mainland China in 12/2022, the incidence of COVID-19 has increased …
measures in mainland China in 12/2022, the incidence of COVID-19 has increased …
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted …
CCHM Maas, DM Kent, AG Dinmohamed… - medRxiv, 2024 - medrxiv.org
Background Risk-based analyses are increasingly popular for understanding
heterogeneous treatment effects (HTE) in clinical trials. For time–to–event analyses, the …
heterogeneous treatment effects (HTE) in clinical trials. For time–to–event analyses, the …
[PDF][PDF] Rapid HbA1c Reduction May Reduce Diabetes-Related Complications in Patients with Severe Hyperglycemia
YY Ou-Yang, HS Chen - Journal ISSN, 2024 - jelsciences.com
Aims: To investigate whether a rapid reduction in HbA1c is more effective for reducing
diabetes-related complications and mortality than a gradual approach in patients with …
diabetes-related complications and mortality than a gradual approach in patients with …